Stocks opened higher Thursday despite hotter-than-expected producer price data. Investors are also eyeing trade tensions and Palo Alto Networks is reporting earnings after the bell. CNBC's Jim Cramer discusses these market movements and more in Thursday's Morning Meeting.
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday's key moments. 1. Stocks opened higher Thursday, shrugging off the hotter-than-expected producer price data . January's PPI rose 0.4%, slightly above the 0.3% estimate, following an already strong consumer price report Wednesday.
Palo Alto's "platformization" strategy, which started early last year, is essentially a bundling of the company's products and services. 3. Shares of DuPont edged higher Thursday, adding to this week's post-earnings gains, after catching an upgrade at Barclays, which took the stock to equal weight from underweight and raised its price target to $89 from $85, implying a 5% upside.
Finance STOCK MARKET INFLATION CYBERSECURITY EARNINGS REPORTS TRADE TENSIONS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CNBC Investing Club with Jim Cramer: Bristol Myers Squibb, DuPont Spinoff, and AI Chip DemandJim Cramer highlights Bristol Myers Squibb as a potential top stock for 2025, discussing the company's promising schizophrenia drug and other potential applications. DuPont accelerates its spinoff timeline, while Cramer expresses a preference for selling Honeywell shares. Taiwan Semiconductor Manufacturing's strong AI chip revenue projections benefit Club holdings Nvidia and Broadcom.
Read more »
CNBC Investing Club with Jim Cramer: Tuesday Market Recap and Trade RecommendationsJim Cramer and the CNBC Investing Club provide a recap of Tuesday's market action, discussing the impact of President Trump's tariff proposals and making trade recommendations for stocks like Coterra Energy, Honeywell, Eli Lilly, and Abbott Labs.
Read more »
CNBC Investing Club with Jim Cramer: Morning Meeting Recap - January 4, 2023CNBC Investing Club with Jim Cramer recap of key moments from Wednesday's 'Morning Meeting' livestream. Stocks rallied on news of a large AI infrastructure project, boosting tech stocks like Microsoft and Nvidia. Jim Cramer weighs in on the potential of AI, discusses his outlook on various portfolio stocks, including Microsoft, Alphabet, and Disney, and highlights his 'buy' recommendations for Meta and Amazon.
Read more »
CNBC Investing Club Recap: Monday's Market Moves, Jim Cramer's Stock PicksJim Cramer and the CNBC Investing Club discuss the market reaction to President Trump's tariffs on Mexico, Canada, and China. Cramer advises a cautious approach, trimming positions in stocks potentially affected by tariffs. He highlights Abbott and Bristol Myers as potential winners in the pharmaceutical and medical device sectors. The Investing Club takes profits on CrowdeStrike following a recent surge and examines other stocks like Tyson Foods, Becton Dickinson, FedEx, and Nucor.
Read more »
CNBC Investing Club with Jim Cramer: Wall Street Rises, Home Depot Surges, Nvidia SoarsJoin CNBC Investing Club with Jim Cramer as we recap the key moments from Monday's market action, including the S&P 500 and Nasdaq's positive start, Home Depot's impressive share performance, and Nvidia's continued surge in the AI chip sector.
Read more »
Jim Cramer's Top 10 Things to Watch ThursdayJim Cramer breaks down his top 10 market thoughts for Thursday, January 23rd. He discusses the performance of the S&P 500, the outlook for chip stocks, the recent earnings reports from GE Aerospace and American Airlines, and the price target changes for several stocks including Abbott Laboratories, GE Vernova, Johnson & Johnson, IBM, Meta Platforms, and Palantir.
Read more »